Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer

NCT00130728

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Kaiser Permanente - Vallejo Vallejo, California, United States
  • University Cancer & Blood Center, LLC; Research Athens, Georgia, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Anne Arundel Health System Research Instit-Annapolis Oncology Ctr Annapolis, Maryland, United States
View Trial Details
Completed

A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

NCT02082210

Conditions
Adenocarcinoma, Advanced Cancer, Bronchial Neoplasms, +31 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
View Trial Details
Completed

Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer

NCT01772797

Conditions
Anaplastic Lymphoma Kinase (ALK), Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • University of Colorado Dept. of Anschutz Cancer (3) Aurora, Colorado, United States
  • Massachusetts General Hospital Mass General Boston, Massachusetts, United States
  • Fox Chase Cancer Center Fox Chase Cancer (2) Philadelphia, Pennsylvania, United States
  • University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

NCT02308020

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +28 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California - San Diego La Jolla, California, United States
  • Univ of California San Francisco San Francisco, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
View all 44 locations
View Trial Details
Completed

Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.

NCT02292550

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Novartis Investigative Site Boston, Massachusetts, United States
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Bologna, BO, Italy
  • Novartis Investigative Site Rozzano, MI, Italy
View Trial Details
Completed

An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)

NCT00674102

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Novartis Investigative Site Aichi, Japan
  • Novartis Investigative Site Osaka, Japan
  • Novartis Investigative Site Shizuoka, Japan
  • Novartis Investigative Site Tokyo, Japan
View Trial Details
Completed

Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer

NCT00888511

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Department of Oncology, Aarhus University Hospital Aarhus, Denmark
  • Department of Oncology, Rigshospitalet Copenhagen, Denmark
  • Department of Oncology, Copenhagen University Hospital at Herlev Herlev, Denmark
  • Department of Oncology, Naestved Hospital Næstved, Denmark
View Trial Details
Completed

Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum

NCT01355497

Conditions
Atrophy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • GTx Investigative Site Birmingham, Alabama, United States
  • GTx Investigative Site Scottsdale, Arizona, United States
  • GTx Investigative Site La Jolla, California, United States
  • GTx Investigative Site Long Beach, California, United States
View all 30 locations
View Trial Details

Related conditions